Subtypes of Breast Cancer
- PMID: 36122153
- Bookshelf ID: NBK583808
- DOI: 10.36255/exon-publications-breast-cancer-subtypes
Subtypes of Breast Cancer
Excerpt
Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The classification of these subtypes has evolved over the years. The most common and widely accepted classification of breast cancer is from an immunohistochemical perspective, based on the expression of the following hormone receptors: estrogen (ER), progesterone (PR) and human epidermal growth factor (HER2). Accordingly, the following four subtypes of breast cancer are widely recognized: luminal A, luminal B, HER2-positive, and triple-negative. With the recent advances in cancer research, and an increased molecular understanding of breast cancer, the current clinical model for classification of breast cancer may be benefit from the addition of several molecular markers such as miRNAs (let-7, miR-155, miR-150, miR-153) and mutations (p53, BRCA 1 and 2 genes). This chapter provides an overview of the characteristics of these four subtypes of breast cancer.
Copyright: The Authors.; The authors confirm that the materials included in this chapter do not violate copyright laws. Where relevant, appropriate permissions have been obtained from the original copyright holder(s), and all original sources have been appropriately acknowledged or referenced.
Conflict of interest statement
Sections
References
-
- Shaath H, Elango R, Alajez NM. Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer. Cancers. 2021;13(21):5350. https://doi.org/10.3390/cancers13215350 . - DOI - PMC - PubMed
-
- Zhang MH, Man HT, Zhao XD, Dong N, Ma SL. Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review) Biomed Rep. 2013;2:41–52. https://doi.org/10.3892/br.2013.187 . - DOI - PMC - PubMed
-
- Miah S, Bagu E, Goel R, Ogunbolude, Dai C, Ward A, et al. Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells. BMC Cancer. 2019;19:78. https://doi.org/10.1186/s12885-018-5186-8 . - DOI - PMC - PubMed
-
- Hicks DG, Lester SC. Hormone Receptors (ER/PR) Diagn Pathol. 2016:430–439. https://doi.org/10.1016/B978-0-323-37712-6.50067-3 . - DOI
-
- Nicolini A, Ferrari P, Duffy MJ. Prognostic and predictive biomarkers in breast cancer: Past, present and future. Semin Cancer Biol. 2018;52(1):56–73. https://doi.org/10.1016/j.semcancer.2017.08.010 . - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous